Search clinical trials for: EOC237

Total 4 results

Shanghai Yiteng Jingang Bio-pharmaceutical Technology...

Recruiting

A Study of EOC237 in Patients With Advanced Solid Tumor

Advanced Solid Tumor

China
Taizhou EOC Pharma Co., Ltd.

Unknown

Study of EOC317 in Chinese Patients With Advanced Solid Tumors

Solid Tumor

China
Taizhou EOC Pharma Co., Ltd.

Completed

Phase I Study of EOC202 Plus Paclitaxel in Chinese Patients With Metastatic Breast Cancer

Solid Tumor, Adult

China
Taizhou EOC Pharma Co., Ltd.

Not yet recruiting

HR Positive, HER2 Negative Advanced Breast Cancer With Progression After Endocrine Therapy

Solid Tumor, Adult

3

Subscribe